Journal Article |
| Ghosh, R., Graham, H., Rivas, P., Tan, J-X., Crosby, K., Bhaskaran, S., Schoolfield, J., Banu, J., Fernandes, G., Yeh, I-Tien and Kumar, A.P. Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management Anticancer Research 2010 Jan;30:847-857.
|
| Ganapathy M, Ghosh R, Xie J, Zhang X, Bedolla R, Schoolfield J, Yeh I, Troyer DA, Olumi AF, Kumar P. Involvement of FLIP in 2-methoxyestradiol induced tumor regression in transgenic adenocarcinoma of mouse prostate (TRAMP) model Clin Cancer Res 2009 Jan;15:1601-1611.
|
| Sri Balasubashini, M., Kunnumakkara, A. B., Bhaskaran, S. B., Kulkarni, K. H., Xu, H., Hu, M., Aggarwal, B. A., Ghosh, R. and Kumar A. P. Butanol fraction containing berberine or related compound from NexrutineR inhibits NFkB signaling and induces apoptosis in prostate cancer cells Prostate 2009 Jan;69:494-504.
|
| Yeh I, Reddick RL, Kumar P. Malignancy arising in seminal vesicles in the transgenic adenocarcinoma of mouse prostate (TRAMP) model The Prostate 2009 Jan;69:755-760.
|
| Kumar P, Schoolfield J, Yeh I, Ghosh R. Loss of NADPH Quinone Oxidoreductase (NQO1) in the prostate and enhanced serum levels of cytokine-induced neutrophil chemoattractant-2alpha(CINC-2alpha) in hormone stimulated Noble rats: potential role in PIN development Translational Oncology 2009 Jan;2:65-72.
|
| Ghosh R
Ganapathy M
Alworth WL
Chan DC
Kumar AP. Combination of 2-methoxyestradiol (2-ME(2)) and eugenol for apoptosis induction synergistically in androgen independent prostate cancer cells J Steroid Biochem Mol Biol 2009 Jan;113(1-2):25-35.
|
| Hardies LJ, Matthew, M., Ali, R., Kumar P. Metabolic adaptation to pharmacologically-induced isulin resistance in Mexican-American obese subjects Diabetes 2008 Jan;57:A416-A416.
|
| Hardies LJ, Cusi K, Wang, S., Kumar P. Amelioration of glucotoxicity with insulin detemir alone or combined with premeal insulin apart improves plasma lioproteins, insulin secretion and hepatic steatosis in poorly controlled T2DM patients Diabetologia 2008 Jan;51:S339-S339.
|
| Ghosh, R., Ganapathy, M., Sribalasubashini, M., Graham, H., Rivas, P., Jianping, X., Robson, C and Kumar AP. Targeting cell survival and apoptotic signaling pathways for prostate cancer management Anticancer Research 2008 Jan;28(5C):3362-3362.
|
| Hardies LJ, Wang, S.Y., Kumar P, Balas, B. Effects of Insulin detemir alone, or with premeal aspart, on plasma lipoproteins, insulin secretion/action and muscle/liver faat in poorly controlled T2DM Diabetes 2008 Jan;57:A572-A572.
|
Abstract |
| Gong, J., Batth, I.S. and Kumar, A.P. Jak/Stat signaling: a potential target for pancreatic cancer management; 2011 Apr. (102ND Annual meeting of the American Association for Cancer Research).
|
| Xie, J., Ghosh, R. and Kumar, A.P. 2-Methoxyestradiol (2-ME2) induces microRNA alterations in prostate cancer cells: Role for miRs in 2-ME2-induced biological effects; 2011 Apr. (102ND Annual meeting of the American Association for Cancer Research).
|
| Xie, J., Rivas, P., Soundararajan, A., David, M.D., Yeh, I-T., Ghosh, R and Kumar, A.P. Interactions among transcription factors as a potential mechanism for inhibiting castrate-resistant prostate cancer (CRPCa) in transgenic adenocarcinoma of mouse prostate (TRAMP) through regulation of FLIP; 2011 Apr. (102ND Annual meeting of the American Association for Cancer Research).
|
| A. Gupta, M. Mann, A.P. Kumar, B.O. Oyajobi. Anti-tumor effect of Nextrutine, a Phellodendron amurense Bark Extract; 2011 Jan. (102ND Annual meeting of the American Association for Cancer Research, April 2011).
|
| Kumar, A.P., Swanson, G.P., Thompson, I.M. and Ghosh, R. Molecular targeted approaches for cancer management; 2011 Jan. (Invited presentation at Plenary session at 98th Indian Science Congress January 2011).
|
| Xie, J., Ghosh, R. and Kumar, Ph.D. AP. 2-Methoxyestradiol modulated microRNAs in prostate cancer cells; 2010 Nov. (12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer).
|
| Graham, H.L., Kumar, A.P. and Ghosh, R. mTOR mediated signaling in the management of malignant melanoma; 2010 Nov. (12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer Therapy).
|
| Gong, J., Freeman, J.W. and Kumar, A.P. NFkB and Stat3 interaction: a potential target for pancreatic cancer management; 2010 Nov. (12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer Therapy).
|
| Ghosh, R., Clark, E., Graham, H.L. and Kumar, A.P. NexrutineR: a novel agent for malignant melanoma; 2010 Nov. (7th International Melanoma CongressSydney, Australia Pigment Cell and Melanoma Research).
|
| Kumar, S., Ghosh, R. and Kumar, A.P. 2-Methoxyestradiol inhibits proliferation and induces apoptosis through modulation of miR-7/FLIP signaling in prostate cancer cells; 2010 May. (101st annual meeting of the American Association of Cancer Research Washington DC, April 17-21 2010).
|
| Li, G., Ghosh, R., Kumar, A.P. Differential effects of resveratrol-induced SIRT1 in prostate cancer: A novel therapuetic target; 2010 Jan. (Proceedings of 101st Annual Meeting of American Association for Cancer Research).
|
| Gong, J., Freeman JW and Kumar, AP. NFkB and Stat3 interaction: a potential target for pancreatic cancer management. 12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer Therapy. November 12-13th 2010; 2010 Jan.
|
| Graham, HL., Kumar AP and Ghosh, R. mTOR mediated signaling in the management of malignant melanoma. 2010; 2010 Jan. (12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer).
|
| Xie, J., Ghosh R., and Kumar AP. 2010. 2-Methoxyestradiol modulated microRNAs in prostate cancer cells. 12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer Therapy. November 12-13th 2010; 2010 Jan.
|
| Xie, J., Ghosh, R., Kumar, A.P. FLIP transcriptional regulation: A potential mechanism for development of androgen independent prostate cancer; 2010 Jan. (Proceedings of 101st Annual Meeting of American Association for Cancer Research).
|
| Polnaszek, N., Soomro, N., Bermejo, C.E., Kumar, A.P. and Ghosh, R. 8-methyl-N-vannillyl 6-nonemide (capsaicin) induces apoptosis in bladder cancer cells independent of p53 status: implications for therapy; 2010 Jan. (Annual Meeting of the American Urological Association, San Francisco, May 29-June 3, 2010).
|
| Xie, J., Ghosh, R. and Kumar, A.P. FLIP transcriptional deregulation: A potential mechanism for development of androgen independent prostate cancer; 2010 Jan. (101st annaul meeting of the American Association of Cancer Research, Washington DC, April 17-21, 201).
|
| Rita Ghosh, Emily Clark, Heather L Graham, Addanki P Kumar. NexrutineR: a novel agent for malignant melanoma 7th International Melanoma Congress, November 4-7, 2010 Sydney, Australia Pigment Cell and Melanoma Research 23: 952-53; 2010 Jan.
|
| Ghosh, R., Clark, E., Graham, H. and Kumar, A.P. NexrutineR: A novel agent for malignant melanoma; 2010 Jan. (7th International Melanoma Congress, Sydney, Nov 4-7, 2010).
|
| Kumar, S.A., Ghosh, R., Kumar, A.P. 2-Methoxyestradiol inhibits proliferation and induces apoptosis through modulation of miR-7/FLIP signaling in prostate cancer cells; 2010 Jan. (Proceedings of 101st Annual Meeting of American Association for Cancer Research).
|
| Kumar, A.P., Xie, J., Graham, H., Rivas, P., Li, G,. Robson, C.H., Gong, J., Garapati, K,. Swanson, G.P., Thompson, I.M., Papanikolaou, N., Yeh, I-T. and Ghosh, R. Bench to bedside application of Phellodendron amurense bark extract: myth or reality?; 2010 Jan. (Invited presentation at 2nd International ICR symposium December 2010).
|
| George, S.K., Kumar, A.P. and Ghosh, R. Multiple roles of E2F1 in eugenol-induced DNA damage signaling and cell survival; 2009 Nov.
|
| CPT Craig H. Robson
Manonmani Ganapathy
Gregory P. Swanson
Niko Papanikolaou
Paul Rivas
Martha A. Hanes
Yeh I-Tien
Rita Ghosh
Addanki P. Kumar. Phellodendoron amurense bark extract as an adjuvant for prostate cancer radio-therapy. 2009 Proceedings of 100th Annual Meeting of the American Association for Cancer Research; 2009 Jan. (Proceedings of American Association for Cancer Research).
|
| Kumar, Ph.D. AP. Prostaglandin signaling: target for pancreatic cancer; 2009 Jan. (Presented at Cell Signaling meeting South Padre Island November 2009).
|
| Robson, C.H., M.C., U.S.A., Ganapathy, M., Swanson, G.P., Natarajan, N., Papanikolaou, N., Hanes, M., Yeh, I-T., Ghosh, R. and Kumar, A.P. Targeting NF-kappa B regulated genes with Phellodendron amurense bark extract may enhance cytotoxic effects of radiation in prostate cancer: A preclinical animal model; 2009 Jan.
|
| Rita Ghosh
Rumu Bose
Addanki P. Kumar. E2F2 in eugenol-induced inhibitory activities in malignant melanoma. 2009 Proceedings of 100th Annual Meeting of the American Association for Cancer Research; 2009 Jan. (Proceedings of American Association for Cancer Research).
|
| Kumar, AP
Ghosh, R
Ganapathy, M
Sribalasubashini, M
Graham, H
Rivas, P
Jianping, X
Robson, C. Targeting cell survival and apoptotic signaling pathways for prostate cancer management; 2009 Jan. (Anticancer Reserch).
|
| Ghosh, R., Bose, R. and Kumar, Ph.D. AP. E2F2 in eugenol induced growth inhibition in melanoma; 2009 Jan. (100th Annual Meeting of the American Association of Cancer Research Denver).
|
| Manonmani Ganapathy
Jianping Xie
Heather Graham
Aria F Olumi
Rita Ghosh
Addanki P. Kumar. Androgen medicated FLIP expression in androgen-sensitive prostatic cancer cell LNCaP as a novel target for 2-Methoxyestradiol (2-Me2) induced apoptosis. 2009 Proceedings of 100th Annual Meeting of American Association for Cancer Research; 2009 Jan. (Proceedings of American Association for Cancer Research).
|
| Kumar, Ph.D. AP. Phellodendron amurense Bark Extract Enhances Radiosensitivity by inhibition of NF-kappa B in; 2008 Jan. (Presented at American Urological Association Annual Meeting).
|
| Kumar, AP
Muralimanohara SriBalasubhasini,
Paul Rivas,
Kunnumakarra, AB,
Aggarwal, BA,
Rita Ghosh. Butanol fraction of Nexrutine targets NFkB pathway in prostate cancer cells. 2008 Proceedings of the 99th Annual Meeting of the American Association for Cancer Research; 2008 Jan. (Proceedings of American Association for Cancer Research).
|
| Kumar, AP
Manonmani Ganapathy,
Paul Rivas,
Rita Ghosh,
Xiaoping Zhang,
Aria F Olumi,. Transcriptional regulation of FLIP as a target in prostate cancer. 2008 Proceedings of the 99th Annual Meeting of the American Associatin for Cancer Research; 2008 Jan. (Proceedings of Amercian Association for Cancer Research).
|
Review Article |
| Kumar AP, Graham HL, Robson C, Thompson, IM and Ghosh R. Natural Products: Potential for developing Phellondendron amurense bark extract for prostate cancer management Mini-rev Med Chem 2010 Jan;10:388-397.
|
